Taken together, these findings support a model in which IL-27 contributes to the establishment or reinforcement of an immunosuppressive microenvironment in CLL through the upregulation of TIM-3 on effector T cells and enhancement of Gal-9 expression. The gene discussed is LGALS9; the disease is B-cell chronic lymphocytic leukemia.